2/18/2014 9:44:56 AM
WASHINGTON--(BUSINESS WIRE)--Members of the Association of Clinical Research Organizations (ACRO) have seen their clinical trials activity in India decrease more than 60 percent since 2010 as a result of a “confusing, inconsistent and arbitrary” regulatory environment, ACRO’s Vice President of Public Affairs, John Lewis, testified before the United States International Trade Commission. The USITC hearing was held last week in Washington, DC.
Help employers find you! Check out all the jobs and post your resume.
comments powered by